Company
VenoStent
Designed to improve vascular surgery outcomes, starting with renal dialysis access
Also known as VenoStent, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Houston, TX, United States
- Legal name
- VenoStent, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
SelfWrap is a bioabsorbable, flexible vascular wrap designed to reduce dialysis access site failures
Funding snapshot
- Total raised
- $29.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $16M2023-07-31
Funding rounds
- Round, 2026
- $10M2026-04-10, SEC form D sold, 29 investors
- Round, 2023
- $16.1M2023-07-05, SEC form D sold, 60 investors
- Round, 2021
- $2.2M2021-01-29, SEC form D sold, 24 investors
- Grant
- $500K2020-07-22, Company stated
- Round, 2020
- $515K2020-05-26, SEC form D sold, 16 investors
- Round, 2019
- $264K2019-06-25, SEC form D sold, 8 investors
- Grant
- $224K2018-06-19, Company stated
- Round, 2018
- $70K2018-03-07, SEC form D sold, 4 investors
Products
- Hardware
- SelfWrap
Loading relationship preview